• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Dr. Bimal Patel Discusses the Rising Costs of Generic Drugs

Article

Bimal Patel, PharmD, MS, Director, Health Outcomes Research, MedImpact Healthcare Systems, Inc., discusses MedImpact's work to identify, analyze, and evaluate generic medications that have become significantly expensive, and effective strategies for managing these costs.

Bimal Patel, PharmD, MS, Director, Health Outcomes Research, MedImpact Healthcare Systems, Inc., discusses MedImpact’s work to identify, analyze, and evaluate generic medications that have become significantly expensive, and effective strategies for managing these costs.

Dr. Patel also discusses the importance of communication among pharmacy benefit managers, plan sponsors, and physicians as generic drug costs continue to rise.

Related Videos
Dr Katherine Tobon
Dr Susan Vadaparampil
Luke Messac at ISC 2026
Ava Liberman at ISC 2026
Alison Holman at ISC 2026
Dr Ameet Patel
Linda Stein Gold, MD
Dr. Emily Fisher at ISC 2026
Angelina Rose Wronski, RN, BS at ISC 2026
© 2026 MJH Life Sciences
AJMC®
All rights reserved.